Abstract
DNA repair enzymes play a pivotal role in platinum-based chemotherapy. Within the gene encoding for the base excision repair enzyme XRCC1, several nonsynonymous polymorphisms have been identified. It has been shown that the Arg399Gln single-nucleotide polymorphism results in a polymorphic enzyme that is less capable of initiating DNA repair. We developed a multiplex pyrosequence assay to simultaneously detect two nonsynonymous polymorphisms within the XRCC1 gene. Both of these polymorphisms resulted in amino acid changes: G/A in codon 399 changes Arg into Gln, and deletion of A in the second position of codon 576 results in a stopcodon. We established the frequency of these mutations in 270 patients suffering from colorectal cancer. Allele frequencies of G in second position of codon 399 and A in the second position codon 576 are 61.1 and 99.6%, respectively, in these patients. This fast and reliable method allows for simultaneous detection of the infrequent mutant C or CT alleles instead of the A deletion at codon 576. The method may be used in pharmacogenetic studies of platinum-based chemotherapy.
MeSH Terms
Colorectal Neoplasms/genetics
DNA Repair
DNA-Binding Proteins/genetics
Gene Frequency
Genetic Predisposition to Disease
Genetic Testing
Humans
Molecular Sequence Data
Mutation
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Sequence Analysis, DNA/methods
X-ray Repair Cross Complementing Protein 1
Chemicals
DNA-Binding Proteins
X-ray Repair Cross Complementing Protein 1
XRCC1 protein, human
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
van der Straaten Tahar
Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, P.O. Box 9600, 2300 RA Leiden, The Netherlands. vanderstra@lumc.nl
Kweekel Dinemarie
Tiller Marco
Bogaartz Judith
Guchelaar Henk-Jan
References (17)
17 references, click to expand
-
Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?
Mutat Res. 2000 Jun 30;460(1):1-15
PMID: 10856830
-
A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.
Anticancer Res. 2001 Jul-Aug;21(4B):3075-9
PMID: 11712813
-
A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Cancer Res. 2001 Dec 15;61(24):8654-8
PMID: 11751380
-
The impact of pharmacogenomics on gastrointestinal cancer therapy.
Pharmacogenomics. 2002 Sep;3(5):625-33
PMID: 12223048
-
Spatial and temporal cellular responses to single-strand breaks in human cells.
Mol Cell Biol. 2003 Jun;23(11):3974-81
PMID: 12748298
-
A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage.
Nucleic Acids Res. 2003 Oct 1;31(19):5526-33
PMID: 14500814
-
Modulation of DNA repair processes by arsenic and selenium compounds.
Toxicology. 2003 Nov 15;193(1-2):161-9
PMID: 14599775
-
[Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Ned Tijdschr Geneeskd. 2003 Nov 8;147(45):2207-12
PMID: 14640057
-
XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
J Clin Oncol. 2004 Jul 1;22(13):2594-601
PMID: 15173214
-
The PARP superfamily.
Bioessays. 2004 Aug;26(8):882-93
PMID: 15273990
-
Assignment of a human DNA-repair gene associated with sister-chromatid exchange to chromosome 19.
Mutat Res. 1986 Aug;174(4):303-8
PMID: 3736579
-
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
Eur J Cancer Clin Oncol. 1988 Feb;24(2):255-62
PMID: 3281842
-
Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange.
Mol Cell Biol. 1990 Dec;10(12):6160-71
PMID: 2247054
-
Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.
Cancer Res. 1998 Feb 15;58(4):604-8
PMID: 9485007
-
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.
Cancer Res. 1999 Jun 1;59(11):2557-61
PMID: 10363972
-
7-Deaza-2'-deoxyadenosine-5'-triphosphate as an alternative nucleotide for the pyrosequencing technology.
Nucleosides Nucleotides Nucleic Acids. 2004;23(10):1583-94
PMID: 15620097
-
Advances in the treatment of metastatic colorectal cancer.
Oncologist. 2005;10 Suppl 3:40-8
PMID: 16368870